• Title of article

    Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis

  • Author/Authors

    Nobuo Wakata، نويسنده , , Toyokazu Saito، نويسنده , , Sachiko Tanaka، نويسنده , , Toshihiko Hirano، نويسنده , , Kitaro Oka، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2003
  • Pages
    4
  • From page
    5
  • To page
    8
  • Abstract
    Tacrolimus hydrate (FK506) reduces myasthenic symptoms due to its immunosuppressive properties. We studied the therapeutic effects of FK506 and noted improvement in 7 of 13 myasthenic patients on the clinical muscle test (myasthenia gravis, MG score). Two other patients with relapsing ocular symptoms improved. We also examined patient sensitivity to FK506, but could not predict such sensitivity before FK506 treatment in the present study.
  • Keywords
    Myasthenia Gravis , Sensitivity test , Tacrolimus hydrate , Immunosuppressant
  • Journal title
    Clinical Neurology and Neurosurgery
  • Serial Year
    2003
  • Journal title
    Clinical Neurology and Neurosurgery
  • Record number

    464036